These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Use of katadolon in the treatment of abuse headache]. Naprienko MV; Filatova EG Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(10):38-41. PubMed ID: 17117672 [TBL] [Abstract][Full Text] [Related]
25. [Effect of maladaptive sets on the clinical picture and prediction of chronic headache of tension]. Podymova IG; Danilov AB Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(4):4-7. PubMed ID: 21512494 [TBL] [Abstract][Full Text] [Related]
26. An open trial of venlafaxine in the treatment of attention-deficit/hyperactivity disorder in children and adolescents. Olvera RL; Pliszka SR; Luh J; Tatum R J Child Adolesc Psychopharmacol; 1996; 6(4):241-50. PubMed ID: 9231317 [TBL] [Abstract][Full Text] [Related]
28. [Psychophysiological features of analgesics abuse headache]. Feoktistov AP; Filatova EG; Veĭn AM Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(10):13-7. PubMed ID: 12449559 [TBL] [Abstract][Full Text] [Related]
29. Extended-release venlafaxine in relapse prevention for patients with major depressive disorder. Simon JS; Aguiar LM; Kunz NR; Lei D J Psychiatr Res; 2004; 38(3):249-57. PubMed ID: 15003430 [TBL] [Abstract][Full Text] [Related]
30. Efficacy and tolerability of venlafaxine extended release in patients with major depressive disorder. Plesnicar BK Psychiatr Danub; 2010 Sep; 22(3):413-7. PubMed ID: 20856184 [TBL] [Abstract][Full Text] [Related]
31. The combined treatment of venlafaxine and quetiapine for treatment-resistant depression: a clinical study. Li X; Xing B; Yu E; Chen W; Wu H J Neuropsychiatry Clin Neurosci; 2013; 25(2):157-60. PubMed ID: 23686035 [TBL] [Abstract][Full Text] [Related]
32. Alteration of central excitation circuits in chronic headache and analgesic misuse. Fusco BM; Colantoni O; Giacovazzo M Headache; 1997 Sep; 37(8):486-91. PubMed ID: 9329230 [TBL] [Abstract][Full Text] [Related]
34. Less mood switching with venlafaxine? Mattes JA Am J Psychiatry; 2006 Sep; 163(9):1642; author reply 1642-3. PubMed ID: 16946194 [No Abstract] [Full Text] [Related]
35. [Treatment-resistant depressions in borderline psychiatry]. Iastrebov DV Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(4):47-50. PubMed ID: 21512501 [TBL] [Abstract][Full Text] [Related]
36. Role of serotonin 5-HT1A receptors in the antidepressant-like effect and the antinociceptive effect of venlafaxine in mice. Berrocoso E; Mico JA Int J Neuropsychopharmacol; 2009 Feb; 12(1):61-71. PubMed ID: 18405417 [TBL] [Abstract][Full Text] [Related]
37. Venlafaxine extended release (XR) in the treatment of generalized anxiety disorder. Sheehan DV J Clin Psychiatry; 1999; 60 Suppl 22():23-8. PubMed ID: 10634352 [TBL] [Abstract][Full Text] [Related]
38. [Muscular-arterial nociceptive reflex in patients with primary headaches]. Esin OR; Esin RG; Tukhbatulin MG; Nasirtdinova AM; Sakhapova LR Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(1):13-5. PubMed ID: 24637811 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of efficacy of the perioperative administration of Venlafaxine or gabapentin on acute and chronic postmastectomy pain. Amr YM; Yousef AA Clin J Pain; 2010 Jun; 26(5):381-5. PubMed ID: 20473044 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of tramadol in combination with doxepin or venlafaxine in inhibition of nociceptive process in the rat model of neuropathic pain: an isobolographic analysis. Wrzosek A; Obara I; Wordliczek J; Przewlocka B J Physiol Pharmacol; 2009 Dec; 60(4):71-8. PubMed ID: 20065499 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]